Heart Failure Clinical Trial
Official title:
THETIS: Non-interventional, Multicenter Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) According to New York Heart Association Functional Classification (NYHA) in Patients With Symptomatic Heart Failure
Cardiac Heart Failure Questionnaire HF-Q) to assess the severity of the symptoms of Heart Failure. In this study, modified and translated, the "four-point" questionnaire by Severo and his associates - Heart Failure Questionnaire HF-Q, is used. The HF-Q Heart Failure Questionnaire consists of four closed questions: the first with four possible answers and the other three questions with the possibility of three simple-choice answers.
An important new element in recent guidelines is the recommendation to prevent the onset of
heart failure syndrome and / or delay its progression. The degree of patient functional
limitation is determined using the New York Heart Association (NYHA) classification, which in
combination with the left ventricular ejection fraction is the main criterion for all
clinical studies in HF.
Specifically, NYHA's functional classification is used to describe the severity of symptoms
and exercise tolerance and includes 4 classes (I-IV) :
Class I: Unbound in physical activity. Conventional physical activity does not cause fatigue,
palpitations or shortness of breath.
Class II: Mild limitation to physical activity. No symptoms in the calm, but ordinary
physical activity causes fatigue, palpitations or shortness of breath.
Class III: Serious restriction to physical activity. No symptoms in the calm, but even mild
physical activity causes fatigue, palpitations or shortness of breath.
Class IV: Inability to perform any physical activity without discomfort. Symptoms and
seclusion. Strengthening the discomfort in any physical activity.
The study evaluates the predictive capacity of the Cardiac Deficiency Questionnaire (HF-Q)
for the occurrence of Adverse Cardiovascular Stroke (MACE) according to the New York Heart
Association (NYHA) Functional Classification of Heart Failure in patients with symptomatic
Heart Failure .
This type of approach may be useful in the reproducibility of the results and the validity of
the NYHA classification system, since the severity of the heart failure symptoms is recorded
on the basis of the patient's own perception.
The term MACE or "Major Unwanted Cardiovascular Syndromes" is undoubtedly the most common and
complex endpoint in cardiology research. Historically, the term MACE appears to be used in
the mid-1990s with its use being mainly limited to the intra-muscular complications
associated with transcutaneous coronary interventions (PCIs). Despite the widespread use of
the term in clinical trials, the definitions of MACE may differ, which makes it difficult to
compare similar studies.
The so-called "classic 3-point MACE" is defined based on the following17:
- Cardiovascular Death
- Myocardial infarction
- Cerebral Episode (Ischemic or Haemorrhagic) In general, MACE terminology is a complex
clinical event and includes endpoints that reflect both safety and efficacy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|